We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIP
4926
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$33.5M
$6K ﹤0.01%
245
-6
-2% -$337
HHS icon
4927
Harte-Hanks
HHS
$20.8M
$6K ﹤0.01%
434
-10,373
-96% -$90.8K
RKTO
4928
Rocket One Inc
RKTO
$19.3M
$6K ﹤0.01%
534
+286
+115% +$3.64K
HYD icon
4929
VanEck High Yield Muni ETF
HYD
$4.42B
$6K ﹤0.01%
+119
New +$6.5K
HYLS icon
4930
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
$6K ﹤0.01%
+159
New +$6.74K
INFU icon
4931
InfuSystem Holdings
INFU
$249M
$6K ﹤0.01%
651
-566
-47% -$4.96K
JOB icon
4932
GEE Group
JOB
$24.9M
$6K ﹤0.01%
+11,520
New +$6.63K
KPRX icon
4933
Kiora Pharmaceuticals
KPRX
$11.5M
$6K ﹤0.01%
35
+5
+17% +$837
LDEM icon
4934
iShares ESG MSCI EM Leaders ETF
LDEM
$33.5M
$6K ﹤0.01%
135
+61
+82% +$3.03K
LTRN icon
4935
Lantern Pharma
LTRN
$33.6M
$6K ﹤0.01%
1,127
+354
+46% +$2.11K
MBRX icon
4936
Moleculin Biotech
MBRX
$4.06M
$6K ﹤0.01%
11
– –
MHH icon
4937
Mastech Digital
MHH
$95.3M
$6K ﹤0.01%
418
-145
-26% -$2.6K
NHTC icon
4938
Natural Health Trends
NHTC
$15.4M
$6K ﹤0.01%
+1,180
New +$7.83K
ONCY
4939
Oncolytics Biotech
ONCY
$95.5M
$6K ﹤0.01%
6,222
+5,275
+557% +$6.41K
OWLT icon
4940
Owlet
OWLT
$182M
$6K ﹤0.01%
+235
New +$11.6K
PHIO icon
4941
Phio Pharmaceuticals
PHIO
$12.7M
$6K ﹤0.01%
+76
New +$7.14K
PLSE icon
4942
Pulse Biosciences
PLSE
$3.2B
$6K ﹤0.01%
4,131
+1,501
+57% +$3.77K
POLA icon
4943
Polar Power
POLA
$6.93M
$6K ﹤0.01%
327
+274
+517% +$5.5K
PRCH icon
4944
Porch Group
PRCH
$1.92B
$6K ﹤0.01%
2,278
-44,977
-95% -$186K
PROK icon
4945
ProKidney
PROK
$289M
$6K ﹤0.01%
+653
New +$6.46K
RAYS
4946
DELISTED
Global X Solar ETF
RAYS
$6K ﹤0.01%
+261
New +$5.1K
REVB icon
4947
Revelation Biosciences
REVB
$4.34M
– –
0
– –
SBEV icon
4948
Splash Beverage Group
SBEV
$2.48M
$6K ﹤0.01%
12
-43
-78% -$15.5K
SCHR
4949
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$6K ﹤0.01%
230
+170
+283% +$4.39K
SCOR icon
4950
Comscore
SCOR
$91.6M
$6K ﹤0.01%
147
-1,757
-92% -$73.1K
196 197
198
199 200

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.